Exemestane (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Exemestane drug offered from Mylan Pharmaceuticals Inc.. This Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | exemestane |
SUBSTANCE NAME: | EXEMESTANE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-03-10 |
END MARKETING DATE: | 0000-00-00 |
Exemestane HUMAN PRESCRIPTION DRUG Details:
Item Description | Exemestane from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/1) |
START MARKETING DATE: | 2017-03-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-5001_3573e3c9-ca05-413f-909f-93607a2ccb79 |
PRODUCT NDC: | 0378-5001 |
APPLICATION NUMBER: | ANDA203315 |
Other EXEMESTANE Pharmaceutical Manufacturers / Labelers: